Related Experiment Video
Updated: Feb 24, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile
Sara Gómez1, Fernando Chaves1, M Angeles Orellana1
1Servicio de Microbiología, Hospital Universitario 12 de Octubre, Avenida de Córdoba s/n, 28041, Madrid, Spain.
Abstract:
Recurrent diarrhea is a common complication of Clostridium difficile infection (CDI). Recurrent CDI (r-CDI) may be produced by the persistence of spores (relapse) or by the acquisition of a new strain (reinfection). In this study, we analyze epidemiological, clinical, microbiological and laboratory data from patients with r-CDI, relapse, and reinfection-CDI over 5 years and compared with a control group (non r-CDI). Among 60 patients with r-CDI, 36 patients had stool samples collected from two or more episodes, which were molecularly analyzed. Based on ribotyping, 63.9% of the samples were relapse, and 36.1% reinfection. In a multivariable logistic regression analysis, previous antibiotic exposure was found to be a risk factor for r-CDI (OR: 2.23; 95% CI: 1.0-4.9; p = 0.04). Patients with relapse had previous antibiotic exposure more frequently than did patients with reinfection (p = 0.03), and patients with reinfection suffered more frequently from chronic liver disease (p = 0.02) than did relapse patients. Relapse patients compared with the control group had a higher percentage of previous antibiotic exposure, although the difference was statistically no significant (73.9% vs. 91.3 p = 0.06). No significant differences for the selected variables were observed between the reinfection and control groups, although we observed a higher percentage of patients with chronic liver disease (30.8% vs 13.3%; p = 0.08). All isolates were sensitive to metronidazole and vancomycin. No significant differences in antibiotic susceptibility were found between the different groups. Sporulation and germination frequency of r-CDI were higher than non r-CDI (p = 0.02 and p < 0.01, respectively). Nevertheless, there were statistically not significant differences between the relapse and reinfection groups. Both frequencies were compared between the first and second episode of CDI for the relapse and reinfection groups, but differences were not observed to be statistically significant. In conclusion, our study showed that the recurrence of CDI was associated with antibiotic use and sporulation/germination frequency, regardless of relapse or reinfection. The use of antibiotics would produce a dysbiosis and favor the persistence of the C. difficile spores and relapse. A possible alteration of the intestinal microbiota and the bile salts produced by chronic liver disease could favor reinfection.
Insights
Recurrent Clostridium difficile infection (CDI) is linked to prior antibiotic use and increased spore activity, regardless of whether it
Area of Science:
- Microbiology
- Infectious Diseases
- Gastroenterology
Background:
- Recurrent Clostridium difficile infection (r-CDI) is a significant clinical challenge, often resulting from spore persistence (relapse) or new strain acquisition (reinfection).
- Understanding the distinct epidemiological and microbiological factors differentiating relapse from reinfection is crucial for effective management strategies.
Purpose of the Study:
- To analyze and compare epidemiological, clinical, microbiological, and laboratory data of patients with recurrent CDI (r-CDI), distinguishing between relapse and reinfection.
- To identify risk factors associated with r-CDI, relapse, and reinfection, and compare them with a non-r-CDI control group.
Main Methods:
- Retrospective analysis of data from 60 r-CDI patients over 5 years, including molecular analysis (ribotyping) of stool samples from multiple episodes.
- Multivariable logistic regression analysis to identify risk factors.
- Comparison of sporulation and germination frequencies between r-CDI and non-r-CDI groups, and between relapse and reinfection subgroups.
Main Results:
- Previous antibiotic exposure was a significant risk factor for r-CDI (OR: 2.23).
- Relapse was more frequent in patients with prior antibiotic exposure (p=0.03), while reinfection was associated with chronic liver disease (p=0.02).
- Higher sporulation and germination frequencies were observed in r-CDI patients compared to controls (p<0.02).
Conclusions:
- Recurrence of CDI is associated with antibiotic use and altered sporulation/germination frequencies, irrespective of relapse or reinfection.
- Antibiotic use likely promotes dysbiosis, favoring C. difficile spore persistence and relapse.
- Chronic liver disease may contribute to reinfection through alterations in intestinal microbiota and bile salt metabolism.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Stages of Infection
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

